{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T20:51:49Z","timestamp":1777927909850,"version":"3.51.4"},"reference-count":132,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T00:00:00Z","timestamp":1666742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"FCT\/MCTES (PIDDAC)","doi-asserted-by":"publisher","award":["LA\/P\/0045\/2020"],"award-info":[{"award-number":["LA\/P\/0045\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"FCT\/MCTES (PIDDAC)","doi-asserted-by":"publisher","award":["UIDP\/00511\/2020"],"award-info":[{"award-number":["UIDP\/00511\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"FCT\/MCTES (PIDDAC)","doi-asserted-by":"publisher","award":["NORTE-01-0145-FEDER-000054"],"award-info":[{"award-number":["NORTE-01-0145-FEDER-000054"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"FCT\/MCTES (PIDDAC)","doi-asserted-by":"publisher","award":["UI\/BD\/150946\/2021"],"award-info":[{"award-number":["UI\/BD\/150946\/2021"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"FCT\/MCTES (PIDDAC)","doi-asserted-by":"publisher","award":["CEECINST\/00049\/2018"],"award-info":[{"award-number":["CEECINST\/00049\/2018"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"European Regional Development Fund (ERDF)","doi-asserted-by":"publisher","award":["LA\/P\/0045\/2020"],"award-info":[{"award-number":["LA\/P\/0045\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"European Regional Development Fund (ERDF)","doi-asserted-by":"publisher","award":["UIDP\/00511\/2020"],"award-info":[{"award-number":["UIDP\/00511\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"European Regional Development Fund (ERDF)","doi-asserted-by":"publisher","award":["NORTE-01-0145-FEDER-000054"],"award-info":[{"award-number":["NORTE-01-0145-FEDER-000054"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"European Regional Development Fund (ERDF)","doi-asserted-by":"publisher","award":["UI\/BD\/150946\/2021"],"award-info":[{"award-number":["UI\/BD\/150946\/2021"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"European Regional Development Fund (ERDF)","doi-asserted-by":"publisher","award":["CEECINST\/00049\/2018"],"award-info":[{"award-number":["CEECINST\/00049\/2018"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"FCT","doi-asserted-by":"publisher","award":["LA\/P\/0045\/2020"],"award-info":[{"award-number":["LA\/P\/0045\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"FCT","doi-asserted-by":"publisher","award":["UIDP\/00511\/2020"],"award-info":[{"award-number":["UIDP\/00511\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"FCT","doi-asserted-by":"publisher","award":["NORTE-01-0145-FEDER-000054"],"award-info":[{"award-number":["NORTE-01-0145-FEDER-000054"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"FCT","doi-asserted-by":"publisher","award":["UI\/BD\/150946\/2021"],"award-info":[{"award-number":["UI\/BD\/150946\/2021"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"FCT","doi-asserted-by":"publisher","award":["CEECINST\/00049\/2018"],"award-info":[{"award-number":["CEECINST\/00049\/2018"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Scientific Employment Stimulus\u2014Institutional Call","doi-asserted-by":"publisher","award":["LA\/P\/0045\/2020"],"award-info":[{"award-number":["LA\/P\/0045\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Scientific Employment Stimulus\u2014Institutional Call","doi-asserted-by":"publisher","award":["UIDP\/00511\/2020"],"award-info":[{"award-number":["UIDP\/00511\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Scientific Employment Stimulus\u2014Institutional Call","doi-asserted-by":"publisher","award":["NORTE-01-0145-FEDER-000054"],"award-info":[{"award-number":["NORTE-01-0145-FEDER-000054"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Scientific Employment Stimulus\u2014Institutional Call","doi-asserted-by":"publisher","award":["UI\/BD\/150946\/2021"],"award-info":[{"award-number":["UI\/BD\/150946\/2021"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Scientific Employment Stimulus\u2014Institutional Call","doi-asserted-by":"publisher","award":["CEECINST\/00049\/2018"],"award-info":[{"award-number":["CEECINST\/00049\/2018"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Alzheimer\u2019s disease (AD) is the most common form of dementia, with a high impact worldwide, accounting for more than 46 million cases. The continuous increase of AD demands the fast development of preventive and curative therapeutic strategies that are truly effective. The drugs approved for AD treatment are classified into acetylcholinesterase inhibitors and N-methyl-D-aspartate receptor antagonists. The therapeutic effectiveness of those drugs is hindered by their restricted access to the brain due to the blood\u2013brain barrier, low bioavailability, and poor pharmacokinetic properties. In addition, the drugs are reported to have undesirable side effects. Several drug delivery systems (DDSs) have been widely exploited to address these issues. DDSs serve as drug carriers, combining the ability to deliver drugs locally and in a targeted manner with the ability to release them in a controlled and sustained manner. As a result, the pharmacological therapeutic effectiveness is raised, while the unwanted side effects induced by the unspecific distribution decrease. This article reviews the recently developed DDSs to increase the efficacy of Food and Drug Administration-approved AD drugs.<\/jats:p>","DOI":"10.3390\/pharmaceutics14112296","type":"journal-article","created":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T07:17:48Z","timestamp":1666768668000},"page":"2296","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Drug Delivery Systems as a Strategy to Improve the Efficacy of FDA-Approved Alzheimer\u2019s Drugs"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9680-8765","authenticated-orcid":false,"given":"D\u00e9bora","family":"Nunes","sequence":"first","affiliation":[{"name":"LEPABE\u2014Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, 4200-465 Porto, Portugal"},{"name":"ALiCE\u2014Associate Laboratory in Chemical Engineering, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, 4200-465 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9841-3967","authenticated-orcid":false,"given":"Joana A.","family":"Loureiro","sequence":"additional","affiliation":[{"name":"LEPABE\u2014Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, 4200-465 Porto, Portugal"},{"name":"ALiCE\u2014Associate Laboratory in Chemical Engineering, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, 4200-465 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8505-3432","authenticated-orcid":false,"given":"Maria Carmo","family":"Pereira","sequence":"additional","affiliation":[{"name":"LEPABE\u2014Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, 4200-465 Porto, Portugal"},{"name":"ALiCE\u2014Associate Laboratory in Chemical Engineering, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, 4200-465 Porto, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neuropharm.2013.07.004","article-title":"Therapeutics of Alzheimer\u2019s disease: Past, present and future","volume":"76","author":"Anand","year":"2014","journal-title":"Neuropharmacology"},{"key":"ref_2","unstructured":"World Health Organization (2017). Global Action Plan on the Public Health Response to Dementia 2017\u20132025, World Health Organization. Licence: CC BY-NC-SA 3.0 IGO."},{"key":"ref_3","unstructured":"(2019). Analysis Reveals Economic Cost of Alzheimer\u2019s Disease and Dementia Are \u2018Tip of the Iceberg, IOS Press."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.arcmed.2012.11.008","article-title":"Alzheimer\u2019s Disease: Critical Notes on the History of a Medical Concept","volume":"43","year":"2012","journal-title":"Arch. Med. Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.3233\/JAD-170732","article-title":"A Long Journey into Aging, Brain Aging, and Alzheimer\u2019s Disease Following the Oxidative Stress Tracks","volume":"62","author":"Mecocci","year":"2018","journal-title":"J. Alzheimer\u2019s Dis. JAD"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1001\/archneur.59.11.1764","article-title":"Survival Following a Diagnosis of Alzheimer Disease","volume":"59","author":"Brookmeyer","year":"2002","journal-title":"Arch. Neurol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s40120-021-00282-z","article-title":"The Development of Pharmacological Therapies for Alzheimer\u2019s Disease","volume":"10","author":"Lin","year":"2021","journal-title":"Neurol. Ther."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jconrel.2020.05.041","article-title":"Nanoparticle-hydrogel superstructures for biomedical applications","volume":"324","author":"Jiang","year":"2020","journal-title":"J. Control. Release"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Lengyel, M., K\u00e1llai-Szab\u00f3, N., Antal, V., Laki, A.J., and Antal, I. (2019). Microparticles, Microspheres, and Microcapsules for Advanced Drug Delivery. Sci. Pharm., 87.","DOI":"10.3390\/scipharm87030020"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.drudis.2019.05.037","article-title":"Hydrogels for sustained delivery of biologics to the back of the eye","volume":"24","author":"Chang","year":"2019","journal-title":"Drug Discov. Today"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3160732","DOI":"10.1155\/2019\/3160732","article-title":"Functional Hydrogels and Their Application in Drug Delivery, Biosensors, and Tissue Engineering","volume":"2019","author":"Wang","year":"2019","journal-title":"Int. J. Polym. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s11095-021-03029-5","article-title":"A Photopolymerized Semi-Interpenetrating Polymer Networks-Based Hydrogel Incorporated with Nanoparticle for Local Chemotherapy of Tumors","volume":"38","author":"Wang","year":"2021","journal-title":"Pharm. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"50376","DOI":"10.1002\/app.50376","article-title":"Synthetic hydrogels: Synthesis, novel trends, and applications","volume":"138","author":"Madihally","year":"2021","journal-title":"J. Appl. Polym. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1021\/acs.molpharmaceut.0c00937","article-title":"ICG\/l-Arginine Encapsulated PLGA Nanoparticle-Thermosensitive Hydrogel Hybrid Delivery System for Cascade Cancer Photodynamic-NO Therapy with Promoted Collagen Depletion in Tumor Tissues","volume":"18","author":"Sun","year":"2021","journal-title":"Mol. Pharm."},{"key":"ref_15","first-page":"4981","article-title":"Nanotechnology-based drug delivery systems for the treatment of Alzheimer\u2019s disease","volume":"10","author":"Chorilli","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/10717544.2018.1428243","article-title":"Therapeutic strategies and nano-drug delivery applications in management of ageing Alzheimer\u2019s disease","volume":"25","author":"Karthivashan","year":"2018","journal-title":"Drug Deliv."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"628","DOI":"10.2174\/1389450120666191118123151","article-title":"Alzheimer\u2019s Disease Targeted Nano-Based Drug Delivery Systems","volume":"21","author":"Altinoglu","year":"2020","journal-title":"Curr. Drug Targets"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"111623","DOI":"10.1016\/j.biopha.2021.111623","article-title":"Advances in developing therapeutic strategies for Alzheimer\u2019s disease","volume":"139","author":"Nguyen","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"630055","DOI":"10.3389\/fbioe.2021.630055","article-title":"Nanomedicine: A Promising Way to Manage Alzheimer\u2019s Disease","volume":"9","author":"Khan","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Poudel, P., and Park, S. (2022). Recent Advances in the Treatment of Alzheimer\u2019s Disease Using Nanoparticle-Based Drug Delivery Systems. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14040835"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1179573520907397","DOI":"10.1177\/1179573520907397","article-title":"Current and Future Treatments in Alzheimer Disease: An Update","volume":"12","author":"Yiannopoulou","year":"2020","journal-title":"J. Cent. Nerv. Syst. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/1570159X11311030006","article-title":"Acetylcholinesterase inhibitors: Pharmacology and toxicology","volume":"11","author":"Colovic","year":"2013","journal-title":"Curr. Neuropharmacol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fnins.2019.00043","article-title":"The Role of NMDA Receptors in Alzheimer\u2019s Disease","volume":"13","author":"Liu","year":"2019","journal-title":"Front. Neurosci."},{"key":"ref_24","first-page":"1642","article-title":"First Donepezil Transdermal Patch Approved for Alzheimer Disease","volume":"327","author":"Larkin","year":"2022","journal-title":"JAMA"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S1474-4422(03)00502-7","article-title":"Treatment of Alzheimer\u2019s disease; current status and new perspectives","volume":"2","author":"Schelterns","year":"2003","journal-title":"Lancet Neurol."},{"key":"ref_26","first-page":"771","article-title":"Alzheimer Disease: Pharmacologic and Nonpharmacologic Therapies for Cognitive and Functional Symptoms","volume":"95","author":"Epperly","year":"2017","journal-title":"Am. Fam. Physician"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.2147\/IJN.S305851","article-title":"Improving Drug Delivery for Alzheimer\u2019s Disease Through Nose-to-Brain Delivery Using Nanoemulsions, Nanostructured Lipid Carriers (NLC) and in situ Hydrogels","volume":"16","author":"Cunha","year":"2021","journal-title":"Int. J. Nanomed."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13195-021-00838-z","article-title":"Aducanumab produced a clinically meaningful benefit in association with amyloid lowering","volume":"13","author":"Cummings","year":"2021","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Homayun, B., Lin, X., and Choi, H.-J. (2019). Challenges and Recent Progress in Oral Drug Delivery Systems for Biopharmaceuticals. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11030129"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"16071","DOI":"10.1038\/natrevmats.2016.71","article-title":"Designing hydrogels for controlled drug delivery","volume":"1","author":"Li","year":"2016","journal-title":"Nat. Rev. Mater."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.2217\/nnm-2016-0019","article-title":"Advances in nanomedicine for the treatment of Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"11","author":"Hernando","year":"2016","journal-title":"Nanomedicine"},{"key":"ref_32","first-page":"5755","article-title":"Current Limitations in the Treatment of Parkinson\u2019s and Alzheimer\u2019s Diseases: State-of-the-Art and Future Perspective of Polymeric Carriers","volume":"25","author":"Origlia","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jconrel.2016.11.025","article-title":"Nanotechnology-based drug delivery systems for Alzheimer\u2019s disease management: Technical, industrial, and clinical challenges","volume":"245","author":"Wen","year":"2017","journal-title":"J. Control. Release"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jconrel.2020.11.049","article-title":"Injectable thermoresponsive hydrogels as drug delivery system for the treatment of central nervous system disorders: A review","volume":"329","author":"Bellotti","year":"2021","journal-title":"J. Control. Release"},{"key":"ref_35","first-page":"569","article-title":"Progress update: Pharmacological treatment of Alzheimer\u2019s disease","volume":"3","author":"Hogan","year":"2007","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/ageing\/afs165","article-title":"Evolution of the evidence on the effectiveness and cost-effectiveness of acetylcholinesterase inhibitors and memantine for Alzheimer\u2019s disease: Systematic review and economic model","volume":"42","author":"Hyde","year":"2013","journal-title":"Age Ageing"},{"key":"ref_37","first-page":"208","article-title":"Drugs for Alzheimer\u2019s disease: Are they effective?","volume":"35","author":"Casey","year":"2010","journal-title":"Pharm. Ther. Peer-Rev. J. Formul. Manag."},{"key":"ref_38","first-page":"237","article-title":"Update on the use of memantine in Alzheimer\u2019s disease","volume":"5","year":"2009","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ejps.2010.05.003","article-title":"Strategy for effective brain drug delivery","volume":"40","author":"Alam","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_40","unstructured":"Kesharwani, P., and Gupta, U. (2018). Chapter 3\u2014Physiology of the Blood\u2013Brain Barrier and Mechanisms of Transport Across the BBB. Nanotechnology-Based Targeted Drug Delivery Systems for Brain Tumors, Academic Press."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/jcbfm.1988.109","article-title":"Mediators of blood-brain barrier dysfunction and formation of vasogenic brain edema","volume":"8","author":"Wahl","year":"1988","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.addr.2011.11.010","article-title":"Modern methods for delivery of drugs across the blood-brain barrier","volume":"64","author":"Chen","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2003.12.016","article-title":"The blood-brain barrier: An overview: Structure, regulation, and clinical implications","volume":"16","author":"Ballabh","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/ca.23083","article-title":"Blood brain barrier: A review of its anatomy and physiology in health and disease","volume":"31","author":"Sharif","year":"2018","journal-title":"Clin. Anat."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fneng.2013.00007","article-title":"The blood-brain barrier: An engineering perspective","volume":"6","author":"Wong","year":"2013","journal-title":"Front. Neuroeng."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"225","DOI":"10.15171\/bi.2016.30","article-title":"Blood-brain barrier transport machineries and targeted therapy of brain diseases","volume":"6","author":"Barar","year":"2016","journal-title":"BioImpacts BI"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"15492","DOI":"10.1016\/j.matpr.2018.04.155","article-title":"Nanotechnology and Nanomedicine: Start small, think big","volume":"5","author":"Kargozar","year":"2018","journal-title":"Mater. Today Proc."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"19200","DOI":"10.1007\/s11356-019-06459-2","article-title":"Advances in nanomedical applications: Diagnostic, therapeutic, immunization, and vaccine production","volume":"27","author":"Kamel","year":"2020","journal-title":"Environ. Sci. Pollut. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"020058","DOI":"10.1063\/1.4949633","article-title":"Recent advances of nanotechnology in medicine and engineering","volume":"1736","author":"Nobile","year":"2016","journal-title":"AIP Conf. Proc."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Saxena, S.K., and Khurana, S.M.P. (2020). Current Advances in Nanotechnology and Medicine. NanoBioMedicine, Springer.","DOI":"10.1007\/978-981-32-9898-9"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1007\/s11095-013-1156-7","article-title":"Nanotechnology-based drug delivery systems for targeting, imaging and diagnosis of neurodegenerative diseases","volume":"30","author":"Pehlivan","year":"2013","journal-title":"Pharm. Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1166\/jnn.2014.9119","article-title":"Nanoparticles and Blood-Brain Barrier: The Key to Central Nervous System Diseases","volume":"14","year":"2014","journal-title":"J. Nanosci. Nanotechnol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.2147\/IJN.S117210","article-title":"Getting into the brain: Liposome-based strategies for effective drug delivery across the blood-brain barrier","volume":"11","author":"Vieira","year":"2016","journal-title":"Int. J. Nanomed."},{"key":"ref_54","unstructured":"Grumezescu, A.M. (2018). Chapter 18\u2014Nanocarriers for the delivery of temozolomide in the treatment of glioblastoma: A review. Design and Development of New Nanocarriers, William Andrew Publishing."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/2211738506666180611100416","article-title":"Lipid Nanoparticles: A Novel Approach for Brain Targeting","volume":"6","author":"Shankar","year":"2018","journal-title":"Pharm. Nanotechnol."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Ribovski, L., Hamelmann, N.M., and Paulusse, J.M.J. (2021). Polymeric Nanoparticles Properties and Brain Delivery. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13122045"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jconrel.2015.10.048","article-title":"Drug delivery of the future: Chasing the invisible gorilla","volume":"240","author":"Park","year":"2016","journal-title":"J. Control. Release"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2016.05.044","article-title":"Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases","volume":"235","author":"Saraiva","year":"2016","journal-title":"J. Control. Release"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1039\/C5NR07161E","article-title":"Nanoformulation and encapsulation approaches for poorly water-soluble drug nanoparticles","volume":"8","author":"Wais","year":"2016","journal-title":"Nanoscale"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2147\/DDDT.S93937","article-title":"Preparation, characterization, and in vivo evaluation of intranasally administered liposomal formulation of donepezil","volume":"10","author":"Ullah","year":"2016","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ijbiomac.2014.03.022","article-title":"Donepezil nanosuspension intended for nose to brain targeting: In vitro and in vivo safety evaluation","volume":"67","author":"Bhavna","year":"2014","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3109\/03639045.2012.758130","article-title":"Preparation, characterization, in vivo biodistribution and pharmacokinetic studies of donepezil-loaded PLGA nanoparticles for brain targeting","volume":"40","author":"Bhavna","year":"2014","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00702-016-1527-4","article-title":"Donepezil loaded PLGA-b-PEG nanoparticles: Their ability to induce destabilization of amyloid fibrils and to cross blood brain barrier in vitro","volume":"124","author":"Baysal","year":"2017","journal-title":"J. Neural Transm."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Topal, G.R., M\u00e9sz\u00e1ros, M., Porkol\u00e1b, G., Szecsk\u00f3, A., Polg\u00e1r, T.F., Sikl\u00f3s, L., Deli, M.A., Veszelka, S., and Bozkir, A. (2021). ApoE-Targeting Increases the Transfer of Solid Lipid Nanoparticles with Donepezil Cargo across a Culture Model of the Blood\u2013Brain Barrier. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13010038"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.etap.2012.04.012","article-title":"Pharmacokinetic behavior and efficiency of acetylcholinesterase inhibition in rat brain after intranasal administration of galanthamine hydrobromide loaded flexible liposomes","volume":"34","author":"Li","year":"2012","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"12076","DOI":"10.1039\/C5NR03474D","article-title":"Galantamine-loaded PLGA nanoparticles, from nano-emulsion templating, as novel advanced drug delivery systems to treat neurodegenerative diseases","volume":"7","author":"Fornaguera","year":"2015","journal-title":"Nanoscale"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.3109\/10717544.2015.1089956","article-title":"Galantamine-loaded solid\u2013lipid nanoparticles for enhanced brain delivery: Preparation, characterization, in vitro and in vivo evaluations","volume":"23","author":"Misra","year":"2016","journal-title":"Drug Deliv."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2174\/1567201815666181004094707","article-title":"Nose to Brain Delivery of Galantamine Loaded Nanoparticles: In-vivo Pharmacodynamic and Biochemical Study in Mice","volume":"16","author":"Sunena","year":"2019","journal-title":"Curr. Drug Deliv."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1021\/acschemneuro.9b00691","article-title":"Preparation, Optimization, and Evaluation of Methoxy Poly(ethylene glycol)-co-Poly(\u03b5-caprolactone) Nanoparticles Loaded by Rivastigmine for Brain Delivery","volume":"11","author":"Mohamadpour","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejps.2012.04.013","article-title":"Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting","volume":"47","author":"Fazil","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1007\/s00210-021-02096-0","article-title":"Pharmacokinetic and pharmacodynamic evaluation of nasal liposome and nanoparticle based rivastigmine formulations in acute and chronic models of Alzheimer\u2019s disease","volume":"394","author":"Rompicherla","year":"2021","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1080\/10717544.2017.1309476","article-title":"Electrosteric stealth Rivastigmine loaded liposomes for brain targeting: Preparation, characterization, ex vivo, bio-distribution and in vivo pharmacokinetic studies","volume":"24","author":"Elbary","year":"2017","journal-title":"Drug Deliv."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2147\/IJN.S39232","article-title":"Potential therapeutic effect of nanobased formulation of rivastigmine on rat model of Alzheimer\u2019s disease","volume":"8","author":"Ismail","year":"2013","journal-title":"Int. J. Nanomed."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1080\/08982104.2020.1787440","article-title":"Dermal pharmacokinetics of rivastigmine-loaded liposomes: An ex vivo\u2013in vivo correlation study","volume":"31","author":"Salimi","year":"2021","journal-title":"J. Liposome Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejps.2015.07.002","article-title":"Application of quality by design approach for intranasal delivery of rivastigmine loaded solid lipid nanoparticles: Effect on formulation and characterization parameters","volume":"78","author":"Shah","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3389\/fnagi.2022.960246","article-title":"QbD-based rivastigmine tartrate-loaded solid lipid nanoparticles for enhanced intranasal delivery to the brain for Alzheimer\u2019s therapeutics","volume":"14","author":"Arora","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"147786","DOI":"10.1016\/j.brainres.2022.147786","article-title":"Polysorbate-coated mesoporous silica nanoparticles as an efficient carrier for improved rivastigmine brain delivery","volume":"1781","author":"Basharzad","year":"2022","journal-title":"Brain Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12951-018-0356-z","article-title":"Memantine loaded PLGA PEGylated nanoparticles for Alzheimer\u2019s disease: In vitro and in vivo characterization","volume":"16","author":"Ettcheto","year":"2018","journal-title":"J. Nanobiotechnol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1021\/acs.bioconjchem.9b00505","article-title":"Lactoferrin Coupled Lower Generation PAMAM Dendrimers for Brain Targeted Delivery of Memantine in Aluminum-Chloride-Induced Alzheimer\u2019s Disease in Mice","volume":"30","author":"Gothwal","year":"2019","journal-title":"Bioconjug. Chem."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.addr.2012.09.010","article-title":"Hydrogels for biomedical applications","volume":"64","author":"Hoffman","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.jsps.2019.08.001","article-title":"Thermo-sensitive hydrogels for delivering biotherapeutic molecules: A review","volume":"27","author":"Huang","year":"2019","journal-title":"Saudi Pharm. J."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"100100","DOI":"10.1016\/j.crphar.2022.100100","article-title":"Galantamine tethered hydrogel as a novel therapeutic target for streptozotocin-induced Alzheimer\u2019s disease in Wistar rats","volume":"3","author":"Rajkumar","year":"2022","journal-title":"Curr. Res. Pharmacol. Drug Discov."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Bashyal, S., Shin, C.Y., Hyun, S.M., Jang, S.W., and Lee, S. (2020). Preparation, Characterization, and In Vivo Pharmacokinetic Evaluation of Polyvinyl Alcohol and Polyvinyl Pyrrolidone Blended Hydrogels for Transdermal Delivery of Donepezil HCl. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12030270"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2478\/acph-2020-0032","article-title":"Preparation, characterization, and pharmacokinetics of thermosensitive nasal gel of donepezil hydrochloride","volume":"70","author":"Gu","year":"2020","journal-title":"Acta Pharm."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.biopha.2018.10.078","article-title":"Microneedles: A smart approach and increasing potential for transdermal drug delivery system","volume":"109","author":"Waghule","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Aldawood, F.K., Andar, A., and Desai, S. (2021). A Comprehensive Review of Microneedles: Types, Materials, Processes, Characterizations and Applications. Polymers, 13.","DOI":"10.3390\/polym13162815"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejpb.2016.06.006","article-title":"Tip-loaded dissolving microneedles for transdermal delivery of donepezil hydrochloride for treatment of Alzheimer\u2019s disease","volume":"105","author":"Kim","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejpb.2016.03.026","article-title":"Microneedle-mediated delivery of donepezil: Potential for improved treatment options in Alzheimer\u2019s disease","volume":"103","author":"Kearney","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Rehman, N.U., Song, C., Kim, J., Noh, I., Rhee, Y.-S., and Chung, H.J. (2022). Pharmacokinetic Evaluation of a Novel Donepezil-Loaded Dissolving Microneedle Patch in Rats. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14010005"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"105331","DOI":"10.1016\/j.ejps.2020.105331","article-title":"Nanoporous microneedle arrays seamlessly connected to a drug reservoir for tunable transdermal delivery of memantine","volume":"150","author":"Vos","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2165\/11531270-000000000-00000","article-title":"Rivastigmine Transdermal Patch Skin Tolerability","volume":"30","author":"Cummings","year":"2010","journal-title":"Clin. Drug Investig."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Guimar\u00e3es, T.M.T., Moniz, T., Nunes, C., Zaharieva, M.M., Kaleva, M., Yoncheva, K., Najdenski, H., Lima, S.A.C., and Reis, S. (2022). Polymeric Microneedles for Transdermal Delivery of Rivastigmine: Design and Application in Skin Mimetic Model. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14040752"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Boyuklieva, R., and Pilicheva, B. (2022). Micro- and Nanosized Carriers for Nose-to-Brain Drug Delivery in Neurodegenerative Disorders. Biomedicines, 10.","DOI":"10.3390\/biomedicines10071706"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijpharm.2016.01.066","article-title":"Development of a novel dry powder inhalation formulation for the delivery of rivastigmine hydrogen tartrate","volume":"501","author":"Simon","year":"2016","journal-title":"Int. J. Pharm."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Haider, M., Elsayed, I., Ahmed, I., and Fares, A. (2021). In Situ-Forming Microparticles for Controlled Release of Rivastigmine: In Vitro Optimization and In Vivo Evaluation. Pharmaceuticals, 14.","DOI":"10.3390\/ph14010066"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"111829","DOI":"10.1016\/j.biopha.2021.111829","article-title":"Systematic development of lectin conjugated microspheres for nose-to-brain delivery of rivastigmine for the treatment of Alzheimer\u2019s disease","volume":"141","author":"Gao","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Froelich, A., Osma\u0142ek, T., Jadach, B., Puri, V., and Michniak-Kohn, B. (2021). Microemulsion-Based Media in Nose-to-Brain Drug Delivery. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13020201"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s11095-017-2279-z","article-title":"Formulation and In-vivo Pharmacokinetic Consideration of Intranasal Microemulsion and Mucoadhesive Microemulsion of Rivastigmine for Brain Targeting","volume":"35","author":"Shah","year":"2018","journal-title":"Pharm. Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2174\/1871527317666180104122347","article-title":"Development of a Nasal Donepezil-loaded Microemulsion for the Treatment of Alzheimer\u2019s Disease: In vitro and ex vivo Characterization","volume":"17","author":"Espinoza","year":"2018","journal-title":"CNS Neurol. Disord.-Drug Targets"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3390\/gels1020162","article-title":"Nanoparticle-Integrated Hydrogels as Multifunctional Composite Materials for Biomedical Applications","volume":"1","author":"Biondi","year":"2015","journal-title":"Gels"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1400010","DOI":"10.1002\/advs.201400010","article-title":"Nanoparticle\u2013Hydrogel Composites: Concept, Design, and Applications of These Promising, Multi-Functional Materials","volume":"2","author":"Thoniyot","year":"2015","journal-title":"Adv. Sci."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Desfran\u00e7ois, C., Auz\u00e9ly, R., and Texier, I. (2018). Lipid Nanoparticles and Their Hydrogel Composites for Drug Delivery: A Review. Pharmaceuticals, 11.","DOI":"10.3390\/ph11040118"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"23838","DOI":"10.1039\/D0NR05053A","article-title":"Intratumoral injection of hydrogel-embedded nanoparticles enhances retention in glioblastoma","volume":"12","author":"Brachi","year":"2020","journal-title":"Nanoscale"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"120954","DOI":"10.1016\/j.ijpharm.2021.120954","article-title":"Thermo-responsive hydrogels for cancer local therapy: Challenges and state-of-art","volume":"606","author":"Rafael","year":"2021","journal-title":"Int. J. Pharm."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Nunes, D., Andrade, S., Ramalho, M.J., Loureiro, J.A., and Pereira, M.C. (2022). Polymeric Nanoparticles-Loaded Hydrogels for Biomedical Applications: A Systematic Review on In Vivo Findings. Polymers, 14.","DOI":"10.3390\/polym14051010"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1016\/j.ijbiomac.2020.09.089","article-title":"Monopotassium phosphate-reinforced in situ forming injectable hyaluronic acid hydrogels for subcutaneous injection","volume":"163","author":"Seo","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Kang, N.-W., Yoon, S.-Y., Kim, S., Yu, N.-Y., Park, J.-H., Lee, J.-Y., Cho, H.-J., and Kim, D.-D. (2021). Subcutaneously Injectable Hyaluronic Acid Hydrogel for Sustained Release of Donepezil with Reduced Initial Burst Release: Effect of Hybridization of Microstructured Lipid Carriers and Albumin. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13060864"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.colsurfb.2019.02.007","article-title":"Development and characterization of nanostructured lipid carrier-based gels for the transdermal delivery of donepezil","volume":"177","author":"Mendes","year":"2019","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"9563","DOI":"10.1038\/s41598-019-46032-y","article-title":"Nasal delivery of donepezil HCl-loaded hydrogels for the treatment of Alzheimer\u2019s disease","volume":"9","author":"Alavi","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1208\/s12249-022-02209-9","article-title":"Donepezil HCl Liposomes: Development, Characterization, Cytotoxicity, and Pharmacokinetic Study","volume":"23","author":"Rajput","year":"2022","journal-title":"AAPS PharmSciTech"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"104794","DOI":"10.1016\/j.chemphyslip.2019.104794","article-title":"Optimization and characterization of rivastigmine nanolipid carrier loaded transdermal patches for the treatment of dementia","volume":"224","author":"Chauhan","year":"2019","journal-title":"Chem. Phys. Lipids"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"121720","DOI":"10.1016\/j.ijpharm.2022.121720","article-title":"Thermosensitive in situ hydrogels of rivastigmine-loaded lipid-based nanosystems for nose-to-brain delivery: Characterisation, biocompatibility, and drug deposition studies","volume":"620","author":"Cunha","year":"2022","journal-title":"Int. J. Pharm."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.colsurfb.2017.08.031","article-title":"Thermosensitive in situ nanocomposite of rivastigmine hydrogen tartrate as an intranasal delivery system: Development, characterization, ex vivo permeation and cellular studies","volume":"159","author":"Salatin","year":"2017","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"20","DOI":"10.15171\/apb.2020.003","article-title":"Formulation and Evaluation of Eudragit RL-100 Nanoparticles Loaded In-Situ Forming Gel for Intranasal Delivery of Rivastigmine","volume":"10","author":"Salatin","year":"2020","journal-title":"Adv. Pharm. Bull."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.colsurfb.2007.06.011","article-title":"Preparation and characteristics of nanostructured lipid carriers for control-releasing progesterone by melt-emulsification","volume":"60","author":"Yuan","year":"2007","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_116","first-page":"10","article-title":"A complete review on: Liposomes","volume":"3","author":"Shashi","year":"2012","journal-title":"Int. Res. J. Pharm."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"116141","DOI":"10.1016\/j.molliq.2021.116141","article-title":"Liposomes as biomembrane models: Biophysical techniques for drug-membrane interaction studies","volume":"334","author":"Andrade","year":"2021","journal-title":"J. Mol. Liq."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"114689","DOI":"10.1016\/j.molliq.2020.114689","article-title":"The biophysical interaction of ferulic acid with liposomes as biological membrane model: The effect of the lipid bilayer composition","volume":"324","author":"Andrade","year":"2021","journal-title":"J. Mol. Liq."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.neuint.2015.07.026","article-title":"Curcumin micelles improve mitochondrial function in neuronal PC12 cells and brains of NMRI mice\u2014Impact on bioavailability","volume":"89","author":"Hagl","year":"2015","journal-title":"Neurochem. Int."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"119844","DOI":"10.1016\/j.biomaterials.2020.119844","article-title":"Neuronal mitochondria-targeted micelles relieving oxidative stress for delayed progression of Alzheimer\u2019s disease","volume":"238","author":"Yang","year":"2020","journal-title":"Biomaterials"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ijbiomac.2022.01.154","article-title":"Ultra-stable dextran conjugated prodrug micelles for oxidative stress and glycometabolic abnormality combination treatment of Alzheimer\u2019s disease","volume":"203","author":"Zhang","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"105008","DOI":"10.1016\/j.neuint.2021.105008","article-title":"Biomaterials in treatment of Alzheimer\u2019s disease","volume":"145","author":"Agrawal","year":"2021","journal-title":"Neurochem. Int."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Nguyen, T.-T.-L., and Maeng, H.-J. (2022). Pharmacokinetics and Pharmacodynamics of Intranasal Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Nose-to-Brain Delivery. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14030572"},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Theunis, C., Crespo-Biel, N., Gafner, V., Pihlgren, M., L\u00f3pez-Deber, M.P., Reis, P., Hickman, D.T., Adolfsson, O., Chuard, N., and Ndao, D.M. (2013). Efficacy and Safety of A Liposome-Based Vaccine against Protein Tau, Assessed in Tau.P301L Mice That Model Tauopathy. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0072301"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","article-title":"Donanemab in Early Alzheimer\u2019s Disease","volume":"384","author":"Mintun","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13195-017-0318-y","article-title":"A phase III randomized trial of gantenerumab in prodromal Alzheimer\u2019s disease","volume":"9","author":"Ostrowitzki","year":"2017","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13195-021-00813-8","article-title":"A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer\u2019s disease with lecanemab, an anti-A\u03b2 protofibril antibody","volume":"13","author":"Swanson","year":"2021","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"e040558","DOI":"10.1002\/alz.040558","article-title":"Brain target occupancy of LY3372689, an inhibitor of the O-GlcNAcase (OGA) enzyme: Translation from rat to human","volume":"16","author":"Shcherbinin","year":"2020","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"e043971","DOI":"10.1002\/alz.043971","article-title":"Evidence that semaphorin 4D is upregulated in neurons in Huntington\u2019s and Alzheimer\u2019s diseases: Effects of a SEMA4D blocking antibody on FDG-PET in a clinical trial, and treatment rationale for its use in AD","volume":"16","author":"Evans","year":"2020","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"e054395","DOI":"10.1002\/alz.054395","article-title":"Encouraging interim results at 9 months from an open-label study of simufilam in patients with Alzheimer\u2019s disease","volume":"17","author":"Burns","year":"2021","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jalz.2015.06.1893","article-title":"Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer\u2019s disease patients","volume":"12","author":"Siemers","year":"2016","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.trci.2017.03.005","article-title":"UB-311, a novel UBITh\u00ae amyloid \u03b2 peptide vaccine for mild Alzheimer\u2019s disease","volume":"3","author":"Wang","year":"2017","journal-title":"Alzheimer\u2019s Dement. Transl. Res. Clin. Interv."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/14\/11\/2296\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:03:01Z","timestamp":1760144581000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/14\/11\/2296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,26]]},"references-count":132,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["pharmaceutics14112296"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics14112296","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,26]]}}}